Avicanna Inc faced a challenging session on the TSX, with its stock price declining significantly.
In yesterday's trading session, Avicanna Inc (AVCN.TO) experienced a notable drop, closing down by 4.55%. This decline comes amid ongoing challenges in the cannabis sector, which continues to face scrutiny and volatility.
Advertisement
Avicanna Inc
AVCN.TO
AVCN.TO
Avicanna Inc
WealthAwesomeMarket cap
$14.78M
52W high
$0.30
52W low
$0.10
1W change
+0.00%
Beta
0.34
Analyst Price Targets
Based on analyst covering AVCN · as of Sep 17, 2026
Wall Street analysts forecast AVCN stock price to rise 536.4% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.70
+536.4% Upside
Current Price
C$0.11
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCN's historical volatility
30-Day Vol
96.5%
Annualized
90-Day Vol
81.0%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.09
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.10 | C$0.07 – C$0.14 |
| 60 trading days | C$0.09 | C$0.06 – C$0.15 |
| 90 trading days | C$0.09 | C$0.05 – C$0.16 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should remain cautious as Avicanna navigates a difficult market landscape, particularly given its recent performance and the broader industry context.
Avicanna Inc's stock closed at CA$0.10
With a market cap of CA$14.1 million, Avicanna's declining stock price highlights investor apprehension in a competitive and uncertain market.
Bull case
Despite the recent decline, Avicanna has launched initiatives like MyMedi.ca, which could strengthen its market position and drive future growth.
Bear case
The stock's recent performance reflects broader struggles within the cannabis industry, raising concerns about Avicanna's ability to maintain growth and profitability.
Market Context
Advertisement
Avicanna's stock decline mirrors broader trends in the cannabis market, where companies are grappling with regulatory challenges and fluctuating consumer demand. Investors are increasingly cautious, leading to volatility in stock prices.
Recent Developments
While Avicanna has made strides with initiatives like the MyMedi.ca integrated healthcare program, the overall market sentiment remains cautious. The company's ability to capitalize on these developments will be critical in the coming months.
Looking Ahead
As Avicanna navigates these challenges, investors should closely monitor its performance and any forthcoming announcements that could impact its market position. For more insights, check out our detailed analysis on Avicanna Inc.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
